Hemophilia B - 26 Studies Found

Terminated : Safety of a New Type of Treatment Called Gene Transfer for the Treatment of Severe Hemophilia B
: Hemophilia B
: 2004-01-26
: Genetic: Adeno-Associated Viral with Human Factor IX
Completed : Study Evaluating Allergic Reactions To Benefix In Hemophilia B Patients
: Hemophilia B
: 2005-10-19
:
  • Drug: blood draw Single blood

Terminated : Hemophilia B Gene Therapy With AAV8 Vector
: Hemophilia B
: 2012-06-12
: Biological: AAV8-hFIX19 One-time IV vector administration.
Completed : A Gene Therapy Study for Hemophilia B
: Hemophilia B
: 2015-06-18
: Genetic: SPK-9001 A novel, bioengineered adeno-associated viral vector carrying human factor IX variant
Active, not recruiting : LTFU for Gene Transfer Subjects With Hemophilia B
: Hemophilia B
: 2007-08-10
Completed : BeneFIX Drug Use Results Survey [All-Case Surveillance]
: Hemophilia B
: 2010-06-28
: Drug: Nonacog Alfa (Genetical Recombination) Patients with
Completed : Study To Compare On-Demand Treatment To A Prophylaxis Regimen Of BeneFIX In Subjects With Moderately Severe to Severe Hemophilia B
: Hemophilia B
: 2011-03-30
:
  • Biological: Nonacog alfa Perio
Completed : Study Evaluating rFIX; BeneFIX® in Hemophilia B
: Hemophilia B
: 2004-10-04
: Drug: rFIX
Active, not recruiting : Study of Recombinant Factor IX Product, IB1001, in Subjects With Hemophilia B
: Hemophilia B
: 2008-10-07
:
  • Biological: IB1001 (On-Demand)

Completed : BAX 326 Surgery Study in Hemophilia B Patients
: Hemophilia B
: 2012-01-09
: Biological: Recombinant factor IX Following a loading dose with BAX326, participants will receive BAX326
<<< Previous | Next >>>